Advertisement
Advertisement

NVNO

NVNO logo

enVVeno Medical Corporation

3.52
USD
0
0.00%
Jan 23, 15:48 UTC -5
Closed
...

enVVeno Medical Corporation Profile

About

enVVeno Medical Corporation is a medical device company. It focuses in the treatment of venous disease. enVVeno Medical Corporation, formerly known as Hancock Jaffe Laboratories Inc., is based in IRVINE, CA.

Info & Links

CEO

Robert Berman

Headquarters

70 DOPPLER
IRVINE, CA 92618, UNITED STATES

Auditor

Marcum

Share holders

72

Employees

31

enVVeno Medical Corporation Statistics

Valuation Measures

Market Capitalization2

61.74M

Enterprise Value

43.83M

Enterprise Value/EBITDA(ttm)

-1.92

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.29

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-48.72%

Return on Invested Capital(ttm)

-48.82%

Return on Assets(ttm)

-45.96%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-22.87M

Net Income Available to Common(ttm)

-21.24M

Diluted EPS(ttm)

-1.29

Share Statistics

Beta (5Y Monthly)

1.21

52-Week Change

-1.95%

S&P 500 52-Week Change

25.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

17.54M

Dividend Yield

0.00%

Float4

14.73M

% Held by Insiders

16.00%

% Held by Institutions

34.71%

Balance Sheet

Total Cash(mrq)

48.38M

Total Cash Per Share(mrq)

2.76

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

22.01%

Quick Ratio(mrq)

22.01%

Book Value Per Share(mrq)

2.70

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.73

Free Cash Flow(ytd)

-11.77M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement